Trademark: 90089206
Status Date
Monday, July 25, 2022
Filing Date
Monday, August 3, 2020
Published for Opposition
Tuesday, October 27, 2020
Abandoned Date
Monday, July 25, 2022
5 Pharmaceutical preparations and human therapeutic preparations and agents for treating and preventing lipid diseases and conditions, cardiometabolic diseases and conditions, and pancreatitis; pharmaceutical preparations and human therapeutic preparations and agents for lowering protein apoc3 and triglyceride levels in blood, controlling blood glucose, and reducing abdominal pain and pancreatic inflammation; antisense oligonucleotides for medical purposes; injectable pharmaceuticals for metabolic diseases and conditions
Jul 25, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 25, 2022
Abandonment - No Use Statement Filed
Dec 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2021
Sou Extension 2 Granted
Dec 8, 2021
Sou Extension 2 Filed
Dec 8, 2021
Teas Extension Received
Jun 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2021
Sou Extension 1 Granted
Jun 7, 2021
Sou Extension 1 Filed
Jun 7, 2021
Teas Extension Received
Dec 22, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 27, 2020
Official Gazette Publication Confirmation E-Mailed
Oct 27, 2020
Published For Opposition
Oct 7, 2020
Notification Of Notice Of Publication E-Mailed
Sep 17, 2020
Approved For Pub - Principal Register
Sep 17, 2020
Examiner's Amendment Entered
Sep 17, 2020
Notification Of Examiners Amendment E-Mailed
Sep 17, 2020
Examiners Amendment E-Mailed
Sep 17, 2020
Examiners Amendment -Written
Sep 17, 2020
Assigned To Examiner
Sep 1, 2020
New Application Office Supplied Data Entered In Tram
Aug 6, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
